Paula Peremiquel Trillas
Research support
Paula Peremiquel-Trillas holds a medical degree (Autonomous University of Barcelona, 2014) and a Master degree in Public Health (Pompeu Fabra University, 2017). She is specialized in Preventive Medicine and Public Health (Vall d’Hebron University Hospital, 2019).
In May 2019 she joined the Cancer Epidemiology Research Program (PREC) at ICO as epidemiologist working on the Screenwide Project while doing her PhD. Since 2020 she is also subinvestigator in the randomized clinical trial evaluating the efficacy, immunogenicity and safety of 9v-HPV vaccine versus placebo in preventing persistent oral infection in adult men (NCT04199689). Since 2021 she coordinates the cervical cancer screening technical office and leads the implementation of the population-based cervical cancer screening protocol in Catalonia.
ORCID: orcid.org/0000-0002-8636-1725
Email: paula.
SELECTED PUBLICATIONS:
Peremiquel-Trillas P, Roura E, Rangel-Sarmiento V, et al. Building the foundations for an organized population-based cervical cancer screening program with primary HPV self-sampling in Catalonia, Spain: findings from a pilot implementation study. Front Med (Lausanne). 2025;12:1580665. doi: 10.3389/fmed.2025.1580665.
Peremiquel-Trillas P, Martínez JM, Paytubi S, et al. Acceptability and somatic mutations in cervicovaginal self-sampling for early endometrial cancer detection in women with Lynch syndrome. Int J Cancer. 2025;156(9):1791-1801. doi: 10.1002/ijc.35368.
Peremiquel-Trillas P, Gómez D, Martínez JM, et al. Cost-effectiveness analysis of molecular testing in minimally invasive samples to detect endometrial cancer in women with postmenopausal bleeding. Br J Cancer. 2023;129(2):325-334. doi: 10.1038/s41416-023-02291-1.
Peremiquel-Trillas P, Paytubi S, Pelegrina B, et al. An Integrated Approach for the Early Detection of Endometrial and Ovarian Cancers (Screenwide Study): Rationale, Study Design and Pilot Study. J Pers Med. 2022;12(7):1074. doi: 10.3390/jpm12071074.
Peremiquel-Trillas P, Frias-Gomez J, Alemany L, et al. Predicting Ovarian-Cancer Burden in Catalonia by 2030: An Age-Period-Cohort Modelling. Int J Environ Res Public Health. 2022;19(3):1404. doi: 10.3390/ijerph19031404.
Lurgain JG, Ouaarab-Essadek H, .., Peremiquel-Trillas P. Exploring cultural competence barriers in the primary care sexual and reproductive health centres in Catalonia, Spain: perspectives from immigrant women and healthcare providers. Int J Equity Health. 2024 Oct 9;23(1):206. doi: 10.1186/s12939-024-02290-5.
Lurgain JG, Ouaarab-Essadek H, ..., Peremiquel-Trillas P. Exploring self-care and cervical cancer prevention attitudes and practices among Moroccan and Pakistani immigrant women in Catalonia, Spain: a comparative qualitative study. BMC Public Health. 2024;24(1):388. doi: 10.1186/s12889-023-17445-2.
Lurgain JG, Peremiquel-Trillas P, Ouaarab-Essadek H, et al. Social influences on Moroccan and Pakistani immigrant women's access and use of cervical cancer screening in Catalonia, Spain: a social network analysis. BMC Womens Health. 2025 Mar 24;25(1):136. doi: 10.1186/s12905-025-03657-8.
Peremiquel-Trillas P, Benavente Y, Martín-Bustamante M, et al. Alkylphenolic compounds and riskof breast and prostate cancer in the MCC-Spain study. Environ Int. 2019 Jan;122:389-399. doi: 10.1016/j.envint.2018.12.007.
Peremiquel-Trillas P, Saura-Lázaro A, Benavente-Moreno Y, et al. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain. BMJ Open. 2022;12(4):e056637. doi: 10.1136/bmjopen-2021-056637.